Our Publications

  • Year: 2023

    CAR-T Cell Therapy and the Gut Microbiota

    Sahana Asokan, Nyssa Cullin, Christoph K. Stein-Thoeringer and Eran Elinav

  • Year: 2023

    Small Intestinal Microbiota Oscillations, Host Effects and Regulation—A Zoom into Three Key Effector Molecules

    Karina Ratiner, Tahel Fachler-Sharp, and Eran Elinav

    READ MORE
  • Year: 2023

    Microbiota-dependent and -independent postnatal development of salivary immunity

    Zubeidat K, Jaber Y, Saba Y, Barel O, Naamneh R, Netanely Y, Horev Y, Eli-Berchoer L, Shhadeh A, Yosef O, Arbib E, Betser-Cohen G, Nadler C, Shapiro H, Elinav E, Aframian DJ, Wilensky A, Hovav AH. 

  • Year: 2023

    Dietary fibers & immunity—more than meets the eye

    Yotam Cohen and Eran Elinav

  • Year: 2022

    Microbiome-phage interactions in inflammatory bowel disease

    Sara Federici, Denise Kviatcovsky, Rafael Valdes-Mas, Eran Elinav

  • Year: 2022

    Smoking-induced microbial dysbiosis in health and disease

    Hagit Shapiro, Kim Goldenberg, Karina Ratiner and Eran Elinav

  • Year: 2022

    Trimming Trem2 and possible impacts on the metabolic syndrome

    Hagit Shapiro, Avner Leshem & Eran Elinav

  • Year: 2022

    Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance

    Jotham Suez, Yotam Cohen, Rafael Valdés-Mas, Uria Mor, Mally Dori-Bachash, Sara Federici, Niv Zmora, Avner Leshem, Melina Heinemann, Raquel Linevsky, Maya Zur, Rotem Ben-Zeev Brik, Aurelie Bukimer, Shimrit Eliyahu-Miller, Alona Metz, Ruthy Fischbein, Olga Sharov, Sergey Malitsky, Maxim Itkin, Noa Stettner, Alon Harmelin, Hagit Shapiro, Christoph K. Stein-Thoeringer, Eran Segal, Eran Elinav.

  • Year: 2022

    Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

    Sara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas,Denise Kviatcovsky, Eyal Weinstock, Yulia Matiuhin, Yael Silberberg, Koji Atarashi, Munehiro Furuichi, Akihiko Oka, Bo Liu, Morine Fibelman, Iddo Nadav Weiner, Efrat Khabra, Nyssa Cullin, Noa Ben-Yishai, Dana Inbar, Hava Ben-David,  Julian Nicenboim, Noga Kowalsman, Wolfgang Lieb, Edith Kario, Tal Cohen, Yael Friedman Geffen,  Lior Zelcbuch, Ariel Cohen, Urania Rappo, Inbar Gahali-Sass, Myriam Golembo, Vered Lev,  Mally Dori-Bachash, Hagit Shapiro, Claudia Moresi, Amanda Cuevas-Sierra, Gayatree Mohapatra, Lara Kern, Danping Zheng, Samuel Philip Nobs, Jotham Suez, Noa Stettner, Alon Harmelin, Naomi Zak,  Sailaja Puttagunta, Merav Bassan, Kenya Honda, Harry Sokol, Corinna Bang, Andre Franke, Christoph Schramm, Nitsan Maharshak, Ryan Balfour Sartor, Rotem Sorek, and Eran Elinav 

  • Year: 2022

    Gastrointestinal microbiome: evaluation of testing technologies. In: Esophageal Diseases and the role of the microbiome: Moving from A(acid) to B(bacteria)- Translational Understanding and Opportunities. (ed. David Johnson).

    Spivak I, Elinav E

  • Year: 2022

    Dimensionality reduction of longitudinal ’omics data using modern tensor factorizations

    Uria Mor, Yotam Cohen, Rafael Valde´s-Mas, Denise Kviatcovsky, Eran Elinav, Haim Avron.

  • Year: 2022

    The spatiotemporal program of zonal liver regeneration following acute injury

    ShaniBen-Moshe, Tamar Veg, Rita Manco, Stav Dan, Delfina Papinutti, Aviezer Lifshitz, Aleksandra A.Kolodziejczyk, Keren Bahar Halpern, Eran Elinav, Shalev Itzkovitz.

  • Year: 2022

    Time-limited diets and the gut microbiota in cardiometabolic disease

    Ratiner K, Shapiro H, Goldenberg K, Elinav E.

    READ MORE
  • Year: 2022

    Utilization of Host and Microbiome Features in Determination of Biological Aging

    Ratiner K, Abdeen SK, Goldenberg K, Elinav E.

    READ MORE
  • Year: 2022

    Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention.

    Spivak I, Elinav E.

    READ MORE
  • Year: 2022

    Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM- a randomized dietary intervention pilot trial

    Rein M, Ben-Yacov O, Godneva A, Shilo S, Zmora N, Kolobkov D, Cohen-Dolev N, Wolf BC, Kosower N, Lotan-Pompan M, Weinberger A, Halpern Z, Zelber-Sagi S, Elinav E (co-corresponding last author), Segal E.

    READ MORE
  • Year: 2022

    Glucosylated nanoparticles for the oral delivery of antibiotics to the proximal small intestine protect mice from gut dysbiosis

    Guorong Zhang, Qin Wang, Wanyin Tao, Wei Jiang, Eran Elinav, Yucai Wang, and Shu Zhu.

  • Year: 2021

    Gut microbiota modulates weight gain in mice after discontinued smoke exposure

    Fluhr L, Mor U, Kolodziejczyk AA, Dori-Bachash M, Leshem A, Itav S, Cohen Y, Suez Z, Molina S, Ayalon N, Valdes-Mas R, Hornstein S, Karbi H, Kviatcovsky D, Livne A, Bukimer A, Eliyahu-Miller S, Metz A, Brandis A, Mehlman T, Kuperman Y, Tsoory M, Stettner N, Harmelin A, Shapiro H, Elinav E

    READ MORE
  • Year: 2021

    Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis

    Beyaz S, Chung C, Mou H, Bauer-Rowe KE, Xifaras ME, Ergin I, Dohnalova L, Biton M, Shekhar K, Eskiocak O, Papciak K, Ozler K, Almeqdadi M, Yueh B, Fein M, Annamalai D, Valle-Encinas E, Erdemir A, Dogum K, Shah V, Alici-Garipcan A, Meyer HV, Özata DM, Elinav E, Kucukural A, Kumar P, McAleer JP, Fox JG, Thaiss CA, Regev A, Roper J, Orkin SH, Yilmaz ÖH.

    READ MORE
  • Year: 2021

    Severe dysbiosis and specific Haemophilus and Neisseria signatures as hallmarks of the oropharyngeal microbiome in critically ill COVID-19 patients.

    de Castilhos J, Zamir E, HippchenT, Rohrbach R, Schmidt S, Hengler S, Schumacher H, Neubauer M, Kunz S, Müller-Esch T, Hiergeist A, Gessner A, Khalid D, Gaiser R, Cullin N, BBeuthien-Baumann B, Krämer A, Bartenschlager R, Jäger D, Müller M, Herth F, Duerschmied D, Schneider J, Schmid RM, Eberhardt JF, Khodamoradi Y, Vehreschild MJGT, Teufel A, Ebert MP, Hau P, Salzberger B, Poeck H, Elinav E, Merle U, Stein-Thoeringer CK.

    READ MORE
  • Year: 2021

    The proteasome regulator PSME4 drives immune evasion and abrogates anti-tumor 2 immunity in NSCLC

    Javitt A, Shmueli MD, Kramer MP, Kolodziejczyk AA, Cohen I, Kamer I, Litchfield K, Bab-Dinitz E, Zadok O, Bar J, Welk V, Rosenwald M, Ulman A, Masarwi S, Wolf-Levy H, Eisenberg-Lerner A, Kacen A, Alon M, Rêgo AT da Fonseca PCA, Stacher-Priehse E, Lindner M, Koch I, Samuels Y, Levin Y, Elinav E, Friedman N, Swanton C, Meiners S, Merbl Y.

    READ MORE
  • Year: 2021

    Reporting guidelines for human microbiome research: the STORMS checklist

    Mirzayi C, Renson A, Geonmic Standard Consortium, Massive Analysis and Quality Control Society, Zohra F, Elsafoury S, Geistlinger L, Kasselman L, Eckenrode K, Van de Wijgert J, Loughman A, Marques FZ, MacIntyre DA, Arumugam M, Azhar R, Beghini F, Bergstrom K, Bhatt A, Bisanz JE, Braun J, Bravo HC, Buck GA, Bushman F, Casero D, Clarke G, Collado MC, Cotter PD, Cryan JF, Demmer RT, Devkota S, Elinav E, Escobar JS, Fettweis J, Finn RD, Fodor AA, Forslund S, Franke A, Furlanello C, Gilbert G, Grice E, Haibe-Kains B, Handley S, Herd P, Holmes S, Jacobs JP, Karstens L, Knight R, Knights D, Koren O, Kwon DS, Langille M, Lindsay B, McGovern D, McHardy AC, McWeeney S, Mueller NT, Nezi L, Olm M, Palm N, Pasolli E, Raes J, Redinbo MR, Rühlemann M, Sartor RB, Schloss PD, Schriml L, Segal E, Shardell M, Sharpton T, Smirnova E, Sokol H, Sonnenburg JL, Srinivasan S, Thingholm LB, Turnbaugh PJ, Upadhyay V, Walls RL, Wilmes P, Yamada T, Zeller G, Zhang M, Zhao N, Zhao L, Bao, Culhane A, Devanarayan V, Dopazo J, Fan X, Fischer M, Jones W, Kusko R, Mason CE, Mercer TR, Sansone S, Scherer A, Shi L, Thakkar S, Tong W, Wolfinger R, Hunter C, Segata N, Huttenhower C, Dowd JB, Jones HE, Waldron L.

    READ MORE
  • Year: 2021

    Microbiome and cancer

    Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer C, Elinav E.

    READ MORE
  • Year: 2021

    Commensal inter-bacterial interactions shaping the microbiota.

    Kern L, Abdeen SK, Kolodziejczyk AA, Elinav E.

    READ MORE
  • Year: 2021

    Postbiotics — when simplification fails to clarify

    Aguilar-Toalá JE, Arioli S, Behare P, Belzer C, Berni Canani R, Chatel JM, D'Auria E, de Freitas MQ, Elinav E, Esmerino EA, García HS, da Cruz AG, González-Córdova AF, Guglielmetti S, de Toledo Guimarães J, Hernández-Mendoza A, Langella P, Liceaga AM, Magnani M, Martin R, Mohamad Lal MT, Mora D, Moradi M, Morelli L, Mosca F, Nazzaro F, Pimentel TC, Ran C, Ranadheera CS, Rescigno M, Salas A, Sant'Ana AS, Sivieri K, Sokol H, Taverniti V, Vallejo-Cordoba B, Zelenka J, Zhou Z.

    READ MORE
  • Year: 2021

    Microbial metabolites in cancer: An interview with Wendy S. Garrett and Eran Elinav

    Elinav E, Garrett WS

    READ MORE
  • Year: 2021

    Gut microbiome and its potential link to personalized nutrition

    Kviatcovsky D, Zheng D, Elinav E.

    READ MORE
  • Year: 2021

    Personalized Postprandial Glucose Response (PPGR)-Targeting Diet versus Mediterranean Diet for Glycemic Control in Prediabetes

    Ben-Yacov O, Godneva A, Rein M, Shilo S, Kolobkov D, Koren N, Dolev N, Travinsky Shmul T, Wolf B, Kosower N, Sagiv K, Lotan-Pompan M, Zmora N, Weinberger A, Elinav E (co-corresponding last author), Segal E.

    READ MORE
  • Year: 2021

    Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner

    Montassier E, Valdés-Mas R, Batard E, Zmora N, Dori-Bachash M, Suez J, Elinav E.

    READ MORE
  • Year: 2021

    Designer fibre meals sway human gut microbes

    Leshem A, Elinav E.

    READ MORE
  • Year: 2021

    Basic Biology of Rhythms and the Microbiome. In: Circadian Rhythms in Bacteria and Microbiomes

    Heinemann M, Ratiner K, Elinav E

    READ MORE
  • Year: 2021

    XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

    Deczkowska A, David E, Pfister D, Safran M, Ramadori P, Li B, Giladi A, Jaitin DA, Barboy O, Cohen M, Yofe I, Gur C, Shlomi-Louaton S, Henri S, Hermon H, Lahat E, Ben-Yakov G, Cohen-Ezra O, Davidov Y, Likhter M, Goitein D, Malissen B, Weiner A, Ben-Ari Z, Heikenwälder M, Weiner A, Elinav E,  Amit I

    READ MORE
  • Year: 2021

    Machine learning in clinical decision making

    Adlung L, Mor U, Cohen Y, Elinav E.

    READ MORE
  • Year: 2021

    Breakthroughs and Bottlenecks in Microbiome Research.

    Liwinski T, Leshem A, Elinav E.

    READ MORE
  • Year: 2021

    Toward a better understanding of intermittent fasting effects: Ramadan fasting as a model.

    Abdeen SK, Elinav E.

    READ MORE
  • Year: 2021

    Remembering past infections: training exercises for gut microbes.

    Samuel P. Nobs, Eran Elinav.

    READ MORE
  • Year: 2021

    Maturation of the neonatal oral mucosa involves distinct epithelium-microbiota interplay.

    Koren N, Zubeidat H, Saba Y, Horev Y, Barel O, Wilharm A, Eli-berchoer L, Shapiro H, Darveau RP, Elinav E, Wilensky A, Prinz I, Bercovier H, Hovav A.

  • Year: 2021

    The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome.

    Finlay BB, Amato KR, Azad M, Blaser MJ, Bosch TCG, Chu H, Dominguez-Bello MG, Ehrlich SD, Elinav E, Geva-Zatoriski N, Gros P, Guillemin K, Keck F, Korem T, McFall-Ngai MJ, Melby MK, Nichter M, Pettersson S, Poinar H, Rees T, Tropini C, Zhao L, Giles Vemick T.

    READ MORE
  • Year: 2021

    Harnessing SmartPhones to Personalize Nutrition in a Time of Global Pandemic.

    Zmora N, Elinav E.

    READ MORE
  • Year: 2021

    The gut microbiome: a key player in the complexity of Amyotrophic lateral sclerosis (ALS).

    Boddy SL, Giovannelli I, Sassani M, Cooper-Knock J, Snyder MP, Segal E, Elinav E, Barker LA, Shaw PJ, McDermott CJ.

    READ MORE
  • Year: 2021

    Infection and cancer. In: Oxford Textbook of Oncology (ed. Michael Baumann).

    Abdin S, Thoeringer-Stein C, Elinav E

  • Year: 2020

    Our Microbiome: On the Challenges, Promises, and Hype.

    Federici S, Suez J, Elinav E.

    READ MORE
  • Year: 2020

    The NLRP6 inflammasome

    Zheng D, Kern L, Elinav E.

    READ MORE
  • Year: 2020

    Acute liver failure is regulated by MYC- and microbiome-dependent programs

    Kolodziejczyk AA, Federici S, Zmora N, Mohapatra G, Dori-Bachash M,Hornstein S, Leshem A, Reuveni D, Zigmond E, Tobar A, Salame TM, Harmelin A, Shlomai A, Shpiro H, Amit I, Elinav E.

    READ MORE
  • Year: 2020

    Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin.

    Htet TD, Godneva A, Liu Z, Chalmers E, Kolobkov D, Snaith JR, Richens R, Toth K, Danta M, Hng TM, Elinav E, Segal E, Greenfield JR, Samocha-Bonet D.

    READ MORE
  • Year: 2020

    The Gut Microbiome and Individual-Specific Responses to Diet

    Leshem A, Segal E, Elinav E

    READ MORE
  • Year: 2020

    Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome

    Mars R, Yang R, Ward T, Houtti M, Priya S, Lekatz HR, Tang X, Sun Z, Kalari KR, Korem T, Bhattarai Y, Zheng Y, Bar N, Frost G, Johnson AG, Treuren W, Han S, Ordog T, Grover M, Sonnenburg J, D’Amato M, Camilleri M, Elinav E, Segal E, Blekhman R, Farrugia G, Swann JR, Knights D, Kashyap PC

    READ MORE
  • Year: 2020

    Diet Diurnally Regulates Small Intestinal Microbiome-Epithelial-Immune Homeostasis and Enteritis

    Tuganbaev T, Mor U, Bashiardes S, Liwinski T, Nobs SP, Leshem A, Dori-Bachash M, Pinker EY, Ratiner K, Adlung LK, Federici S, Kleimeyer C, Moresi C, Yamada T, Cohen Y, Massalha H, Massasa E, Kuperman Y, Koni PA, Harmelin A, Gao N, Itzkovitz S, Honda, Shapiro H, Elinav E.

    READ MORE
  • Year: 2020

    Phages and their potential to modulate the microbiome and immunity

    Federici S, Nobs SP, Elinav E.

    READ MORE
  • Year: 2020

    High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function.

    Grosheva I, Zheng D, Levy M, Polansky O, Lichtenstein A, Golani O, Dori-Bachash M, Moresi C, Shapiro H, Del Mare-Roumani S, Valdes-Mas R, He Y, Karbi H, Chen M, Harmelin A, Straussman R, Yissachar N, Elinav E (co-corresponding last author), Geiger B.

    READ MORE
  • Year: 2020

    Inflammasome activation and regulation: toward a better understanding of complex mechanisms

    Zheng D, Liwinski T, Elinav E.

    READ MORE
  • Year: 2020

    Amyotrophic lateral sclerosis and intestinal microbiota—toward establishing cause and e!ec

    Gotkine M, Kviatcovsky D, Elinav E.

    READ MORE
  • Year: 2020

    Nutrition Regulates Innate Immunity in Health and Disease

    Nobs SP, Zmora N, Elinav E.

    READ MORE
  • Year: 2020

    Niche rather than origin dysregulates mucosal Langerhans cells development in aged mice

    Horev Y, Salameh R, Nassar M, Capucha T, Saba Y, Barel O, Zubeidat K, Matanes D, Leibovich A, Heyman O, Eli-Berchoer L, Hanhan S, Betser-Cohen G, Shapiro H, Elinav E, Becovier H, Wilensky A, Hovav A.

    READ MORE
  • Year: 2020

    Immune-Microbiota Interplay and Colonization Resistance in Infection

    Leshem E, Liwinski, T, Elinav E.

    READ MORE
  • Year: 2020

    Interaction between microbiota and immunity in health and disease

    Zheng D, Liwinski T, Elinav E.

    READ MORE
  • Year: 2020

    Moving from probiotics to precision probiotics

    Veiga P, Suez J, Derrien M, Elinav E.

    READ MORE
  • Year: 2020

    Circadian Influences of Diet on the Microbiome and Immunity

    Zheng D, Ratiner K, Elinav E.

    READ MORE
  • Year: 2020

    Microbiome genomics for cancer prediction

    Adlung L, Elinav E, Greten TF and Korangy F

    READ MORE
  • Year: 2020

    The microbiome and cytosolic innate immune receptors

    Liwinski T, Zheng D, Elinav E.

    READ MORE
  • Year: 2020

    The microbiota programs DNA methylation to control intestinal homeostasis and inflammation

    Ansari I, Raddatz G, Gutenkunst J, Ridnik M, Cohen D, Abu-Remaileh M, Tuganbaev T, Shapiro H, Pikarsky E, Elinav E, Lyko F, Bergman Y.

    READ MORE
  • Year: 2020

    Are noncommunicable diseases communicable?

    Finlay B, Blaser MJ, Bosch TCG, Domingues-Bello MG, Elinav E, McFall-Ngai, M, Melby M, Muehlmann SR, Sansonetti PJ (alphabetical order).

    READ MORE
  • Year: 2019

    Harnessing the Microbiota for Therapeutic Purposes

    Liwinski T, Elinav E.

    READ MORE
  • Year: 2019

    Personalized nutrition: Are we there yet?

    Bashiardes S, Abdeen SK, Elinav E.

    READ MORE
  • Year: 2019

    Leukocyte-Specific siRNA Delivery Revealing IRF8 as a Potential Anti-Inflammatory Target

    eiga N, Goldsmith M, Diesendruck Y, Ramishetti S, Rosenblum D, Elinav E, Behlke MA, Benhar I, Peer D.

    READ MORE
  • Year: 2019

    Embrace the fat when getting old

    Adlung L, Amit I, Elinav E.

    READ MORE
  • Year: 2019

    Vaginal microbiome transplantation in women with intractable bacterial vaginosis

    Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U, Strahilevitz J, Moses AE, Shapiro H, Yagel S, Elinav E.

    READ MORE
  • Year: 2019

    Citrobacter rodentium induces rapid and unique metabolic and inflammatory responses in mice suffering from severe disease.

    Carson D, Barry R, Hopkins EGD, Roumeliotis TI, García-Weber D, Mullineaux-Sanders C, Elinav E, Arrieumerlou C, JS. Choudhary, Frankel G.

    READ MORE
  • Year: 2019

    Diet–microbiota interactions and personalized nutrition.

    Kolodziejczyk AA, Zheng D, Elinav E.

    READ MORE
  • Year: 2019

    The intestinal microbiota fuelling metabolic inflammation

    Tilg H, Zmora N, Adolph TE, ran Elinav E.

    READ MORE
  • Year: 2019

    Walk on the wildling side.

    Nobs SP, Elinav E.

    READ MORE
  • Year: 2019

    When cultures Meet: The landscape of “social” interactions between the host and its indigenous microbes.

    Geva‐Zatorsky N, Elinav E, Pettersson S.

    READ MORE
  • Year: 2019

    Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner

    Jaitin DA, Adlung L, Thaiss CA, Weiner A, Li B, Descamps H, Lundgren P, Bleriot C, Liu Z, Deczkowska A, Keren-Shaul H, David E, Zmora N, Eldar SM, Lubezky N, Shibolet O, Hill DA, Lazar MA, Colonna M, Ginhoux F, Shapiro H, Elinav E (co-corresponding last author), Amit I.

  • Year: 2019

    Potential roles of gut microbiome and metabolites in modulating ALS in mice

    Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, Zabari M, Ben-Zeev Brik R, Kviatcovsky D, Zmora N, Cohen Y, Bar N, Levi Y, Amar N, Mehlman T, Brandis A, Biton I, Kuperman Y, Tsoory M, Alfahel L, Harmelin A, Schwartz M, Israelson A, Arike L, Johansson MEV, GC Hansson, Gotkine M, Segal E, Elinav E.

  • Year: 2019

    Fecal microbial transplantation and its potential application in cardiometabolic syndrome.

    Leshem A, Horesh N, Elinav E.

    READ MORE
  • Year: 2019

    The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs.

    Virtue AT, McCright SJ, Wright JM, Jimenez MT, Mowel WK, Kotzin JJ, Joannas L, Basavappa MG, Spencer SP, Clark ML, Eisennagel SH, Williams A, Levy M, Manne S, Henrickson SE, Wherry EJ, Thaiss CA, Elinav E, Henao-Mejia J.

    READ MORE
  • Year: 2019

    The cancer microbiome.

    Elinav E, Garrett WS, Trinchieri G, Wargo J.

    READ MORE
  • Year: 2019

    The pros, cons, and many unknowns of probiotics.

    Suez J, Zmora N, Segal E, Elinav E.

    READ MORE
  • Year: 2019

    The Next Quarter Century

    Elinav E.

    READ MORE
  • Year: 2019

    Microbiome diurnal rhythmicity and its impact on host physiology and disease risk

    Nobs SP, Tuganbaev T, Elinav E.

    READ MORE
  • Year: 2019

    Probiotics in the next-generation sequencing era.

    Suez J, Zmora N, Elinav E.

    READ MORE
  • Year: 2019

    No guts, no research glory

    Elinav E.

    READ MORE
  • Year: 2019

    Transforming medicine with the microbiome

    Zmora N, Soffer E, Elinav E.

    READ MORE
  • Year: 2018

    Mutual interplay between IL-17–producing γδT cells and microbiota orchestrates oral mucosal homeostasis

    Wilharm A, Tabib Y, Nassar M, Reinhardt A, Mizraji G, Sandrock I, Heyman O, Barros-Martins J, Aizenbud Y, Khalaileh A, Eli-Berchoer L, Elinav E, Wilensky A, Förster R, Bercovier H, Prinz I Hovav A.

    READ MORE
  • Year: 2018

    Sequential BMP7/TGF-β1 signaling and microbiota instruct mucosal Langerhans cell differentiation

    Capucha T, Koren N, Nassar M, Heyman O, Nir T, Levy M, Zilberman‑Schapira G, Zelentova K, Eli‑Berchoer L, Zenke M, Hieronymus T, Wilensky A, Bercovier H, Elinav E, Clausen BE, Hovav A.

    READ MORE
  • Year: 2018

    The role of the microbiome in NAFLD and NASH.

    Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E.

    READ MORE
  • Year: 2018

    Translating microbiome futures

    Taroncher-Oldenburg G, Jones S, Blaser M, Bonneau R, Christey P, Clemente JC, Elinav E, Ghedin E, Huttenhower C, Kelly, D, Kyle D, Littman D, Maiti A, Maue A, Olle B, Segal L, van Hylckama-Vlieg JET, Wang J.

    READ MORE
  • Year: 2018

    The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses.

    Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Serafini N, Pevsner-Fischer M, Yu L, Elinav E, Di Santo JP, Choudhary JS, Frankel G.

    READ MORE
  • Year: 2018

    You are what you eat: diet, health and the gut microbiota

    Zmora N, Suez J, Elinav E.

    READ MORE
  • Year: 2018

    Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features.

    Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, Kotler E, Zur M, Regev-Lehavi D, Ben-Zeev Brik R, Federici S, Cohen Y, Linevsky R, Rothschild D, Moor AE, Ben-Moshe S, Harmelin A, Itzkovitz S, Maharshak N, Shibolet O, Shapiro H, Pevsner-Fischer M, Sharon I, Halpern Z, Segal E, Elinav E.

    READ MORE
  • Year: 2018

    Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT.

    Suez J, Zmora N, Zilbrerman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, Zur M, Regev-Lehavi D, Ben-Zeev Brik R, Federici S, Horn M, Cohen Y, Moor A, Zeevy, D, Korem T, Harmelin A, Itzkovitz S, Maharshak N, Shibolet O, Pevnser-Fishcher M, Shapiro H, Sharon I, Halpern Z, Segal E, Elinav E.

    READ MORE
  • Year: 2018

    Towards utilization of the human genome and microbiome for personalized nutrition

    Bashiardes S, Godneva A, Elinav E (co-corresponding last author), Segal E.

    READ MORE
  • Year: 2018

    Transmissible inflammation-induced colorectal cancer in inflammasome-deficient mice

    Hu B, Friedman G, Elinav E, Flavell RA.

    READ MORE
  • Year: 2018

    NLRP6 and dysbiosis: Avoiding the luring attraction of over-simplification.

    Elinav E, Henao-Mejia J, Strowig T, Flavell RA.

    READ MORE
  • Year: 2018

    Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis

    Johnston DGW, Williams MA, Thaiss CA, Cabrera-Rubio R, Raverdeau M, McEntee C, Cotter PD, Elinav E, O’Neill LAJ, Corr SC.

    READ MORE
  • Year: 2018

    Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection

    Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, Braverman S, Tengeler AC, Barak O, Elazar M, Ben-Zeev R, Lehavi-Regev D, Katz MN, Pevsner-Fischer M, Gertler A, Halpern Z, Harmelin A, Aamar S, Serradas P, Grosfeld A, Shapiro H, Geiger G, Elinav E.

    READ MORE
  • Year: 2018

    Environment dominates over host genetics in shaping human gut microbiota.

    Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN, Bar N, Shilo S, Lador D, Vila AV, Zmora N, Pevsner-Fischer M, Israeli D, Kosower N, Malka G, Wolf BC, Avnit-Sagi T, Lotan-Pompan M, Weinberger A, Halpern Z, Carmi S, Fu J, Wijmenga C, Zhernakova A, Elinav E (co-corresponding last author), Segal E.

    READ MORE
  • Year: 2018

    Sieving through gut models of colonization resistance

    Mullineaux-Sanders C, Suez J, Elinav E (co-corresponding last author), Frankel G.

    READ MORE
  • Year: 2018

    Bile acids in glucose metabolism in health and disease.

    Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E.

    READ MORE
  • Year: 2017

    The Personalized Diet: The Pioneering Program to Lose Weight and Prevent Disease

    Segal E & Elinav E

    (Translated to English, Hebrew, Spanish, French, German, Check, Chinese, Portuguese, Italian, Polish).

  • Year: 2017

    https://wpre.weizmann.ac.il/immunology/elinav/node/add/publication

    Mullineaux-Sanders C, Collins JW, Ruano-Gallego D, Levy M, Pevsner-Fischer M, Glegola-Madejska IT, Sagfors AM, Wong JLC, Elinav E, Crepin FV, Frankel G.

    READ MORE
  • Year: 2017

    Our Gut Microbiome: The Evolving Inner Self

    Kundu P, Blacher E, Elinav E (co-corresponding last author), Pettersson S.

    READ MORE
  • Year: 2017

    The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota

    Alteber Z, Sharbi-Yunger A, Pevsner-Fischer M, Blat D, Roitman L, Tzehoval E, E Elinav, Eisenbach L.

    READ MORE
  • Year: 2017

    Microbiome at the Frontier of Personalized Medicine

    Kashyap PC, Chia N, Nelson H, Segal E, Elinav E.

    READ MORE
  • Year: 2017

    Citrobacter rodentium Subverts ATP Flux and Cholesterol Homeostasis in Intestinal Epithelial Cells In Vivo

    Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Carson D, Pevsner-Fischer M, Furniss RCD, Dougan G, Bachash-Dori M, Yu L, Clements A, Collins JW, Elinav E, Larrouy-Maumus GJ, Choudhary JS, Frankel G.

    READ MORE
  • Year: 2017

    NFIL-trating the Host Circadian Rhythm— Microbes Fine-Tune the Epithelial Clock

    Thaiss CA, Nobs SP, Elinav E.

    READ MORE
  • Year: 2017

    Ectopic colonization of oral bacteria in the intestine drives Th1 cell induction and inflammation

    Atarashi K, Suda W, Luo C, Kawaguchi T, Motoo L, Narushima S, Kiguchi Y, Yasuma K, Watanabe E, Tanoue T, Thaiss CA, Sato M, Toyooka K, Said HS, Yamagami H, Rice SA, Gevers D, RC Johnson, Segre JA, Chen K, Kolls JK, Elinav E, Morita H, Xavier RJ, Hattori M, Honda K.

    READ MORE
  • Year: 2017

    Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial

    Sherf-Dagan S, Zelber-Sagi S, Zilberman-Schapira G, Webb M, Buch A, Keidar A, Raziel A, Sakran N, Goitein D, Goldenberg N, Ali Mahdi J, Pevsner-Fischer M, Zmora N, Dori-Bachash M, Segal E, Elinav E, Shibolet O.

    READ MORE
  • Year: 2017

    Circadian Coordination of Antimicrobial Responses

    Tognini P, Thaiss CA, Elinav E (co-corresponding last author), Sassone-Corsi P.

    READ MORE
  • Year: 2017

    The microbiome in anti-cancer therapy

    Bashiardes S, Tuganbaev T, Federici S, Elinav E.

    READ MORE
  • Year: 2017

    Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses.

    Korem T, Zeevi D, Zmora N, Weissbrod O, Bar N, Lotan-Pompan M, Avnit-Sagi T, Kosower N, Malka G, Rein M, Suez J, Goldberg BZ, Weinberger A, Levy AA, Elinav E (co-corresponding last author) Segal E.

    READ MORE
  • Year: 2017

    The path towards microbiome-based metabolite treatment.

    Suez J, Elinav E.

    READ MORE
  • Year: 2017

    Inflammasomes and intestinal inflammation.

    Zmora N, Levy M, Pevsner-Fischer M, Elinav E.

    READ MORE
  • Year: 2017

    The remedy within: will the microbiome fulfill its therapeutic promise?

    Thaiss CA, Elinav E.

    READ MORE
  • Year: 2017

    Post-dieting weight gain: the role of persistent microbiome changes

    Thaiss CA, Shapiro H, Elinav E.

    READ MORE
  • Year: 2017

    The role of the immune system in metabolic health and disease.

    Zmora N, Bashiardes S, Levy M, Elinav E.

    READ MORE
  • Year: 2017

    Dysbiosis and the immune system

    Levy, M Kolodziejczyk AA, Thaiss CA, Elinav E.

    READ MORE
  • Year: 2017

    NLRP6: A Multifaceted Innate Immune Sensor.

    Levy M, Shapiro H, Thaiss CA, Elinav E.

    READ MORE
  • Year: 2017

    The role of epigenetics in the crosstalk between microbial and host genomes. In: The handbook for nutrition, diet and epigenetics (ed. Victor Preeny).

    Pevsner-Fischer M, Zmora N, Braverman Sophie, Elinav E

  • Year: 2017

    The gut microbiome and hypertension.

    Pevsner-Fischer M, Blacher E, Tatirovsky E, Ben-Dov IZ, Elinav E.

    READ MORE
  • Year: 2017

    Microbiome-Modulated Metabolites at the Interface of Host Immunity

    Blacher E, Levy M, Tatirovsky E, Elinav E.

    READ MORE
  • Year: 2017

    Host-Microbiome interactions in health and diseases. In: Crossing Boundaries in Science- Can We Control the World? (ed. Johannes Fritsch).

    Elinav E.

  • Year: 2016

    Persistent microbiome alterations modulate the rate of post-dieting weight regain

    Thaiss CA, Itav S, Rothschild D, Meijer M, Levy M, Moresi C,
 Dohnalová L, Braverman S, Rozin S, Malitsky S, Dori-Bachash M, Kuperman Y, Biton I, Gertler A, Harmelin A, Shapiro H, Halpern Z, Aharoni A, Segal E, Elinav E.

    READ MORE
  • Year: 2016

    GAS6 is a key homeostatic immunological regulator of host–commensal interactions in the oral mucosa.

    Nassar M, Tabib Y, Capuch T, Mizraji G, Nir T, Pevsner-Fischer M, Zilberman-Schapira G, Heyman O, Nussbaum G, Bercovier H, Wilensky A, Elinav E, Burstyn-Cohen T, Hovav A.

    READ MORE
  • Year: 2016

    Microbiota diurnal rhythmicity programs host transcriptome oscillations.

    Thaiss CA, Levy M, Korem T, Dohnalova L, Shapiro H, Jaitin DA, David E, Winter DR, Gury-Ben Ari M, Tatirovsky E, Tuganbaev T, Federici S, Zmora N, Zeevi N, Dori-Bachash M, Pevsner-Fischer M, Kartvelishvily E, Brandis A, Harmelin A, Shibolet O, Halpern Z, Honda K, Amit I, Segal E, Elinav E.

    READ MORE
  • Year: 2016

    Microbiome, metabolites and host immunity

    Levy M, Blacher E, Elinav E.

    READ MORE
  • Year: 2016

    The DNA-sensing AIM2 inflammasome controls radiation-induced cell 
death and tissue injury.

    Hu B, Jin C, Li H, Tong J, Ouyang X, Cetinbas NM, Zhu S, Strowig T, Lam FC, Zhao C, Henao-Mejia J, Yilmaz O, Fitzgerald KA, Eisenbarth SC, Elinav E, Flavell RA.

    READ MORE
  • Year: 2016

    Personalized microbiome-based approaches to metabolic syndrome management and prevention

    Shapiro H, Suez J, Elinav E.

    READ MORE
  • Year: 2016

    The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome

    Gury-BenAri M, Thaiss CA, Serafini N, Rachel Winter D, Giladi A, Lara-Astiaso D, Levy M, Salame TM, Weiner A, David E, Shapiro H, Dori-Bachash M, Pevsner-Fischer N, Lorenzo-Vivas E, Keren-Shaul H, Paul F, Harmelin A, Eberl G, Itzkovitz S, Tanay A, Di Santo JP, Elinav E (co-corresponding last author) Amit I.

    READ MORE
  • Year: 2016

    Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells

    Chao K, Zhang S, Qiu Y, Chen X, Zhang X, Cai C, Peng Y, Mao R, Pevsner-Fischer M, Ben-horin S, Elinav E, Zeng Z, Chen B, He Y, Xiang AP, Chen M.

    READ MORE
  • Year: 2016

    Metabolites: messengers between the microbiota and the immune system

    Levy M, Thaiss CA, Elinav E.

    READ MORE
  • Year: 2016

    The microbiome and innate immunity.

    Thaiss CA, Zmora N, Levy M, Elinav E.

    READ MORE
  • Year: 2016

    Microglia development follows a stepwise program to regulate brain homeostasis.

    Matcovitch-Natan O, Winter DR, Giladi A, Aguilar SV, Spinrad A, Sarrazin S, Ben-Yehuda H, David E, González FZ, Perrin P, Keren-Shaul H, Gury M, Lara-Astaiso D, Thaiss CA, Cohen M, Halpern KB, Baruch K, Deczkowska A, Lorenzo-Vivas E, Itzkovitz S, Elinav E, Sieweke MH, Schwartz M, Amit I.

    READ MORE
  • Year: 2016

    Non-alcoholic fatty liver and the gut microbiota

    Bashiardes S, Shapiro H, Rozin S, Shibolet O, Elinav E.

    READ MORE
  • Year: 2016

    The gut microbiome in human immunodeficiency virus infection.

    Zilberman-Schapira G, Zmora N, Itav S, Bashiardes S, Elinav H, Elinav E.

    READ MORE
  • Year: 2016

    It’s in the milk: Feeding the microbiome to promote infant growth.

    Bashiardes S, Thaiss CA, Elinav E.

    READ MORE
  • Year: 2016

    Use of Metatranscriptomics in Microbiome Research

    Bashiardes S, Zilberman-Schapira G, Elinav E.

    READ MORE
  • Year: 2016

    Taking it personally: Personalized utilization of the human microbiome in health and disease.

    Zmora N, Zeevi D, Korem T, Segal E, Elinav E.

    READ MORE
  • Year: 2016

    Role of the microbiome in the normal and aberrant glycemic response

    Suez J, Shapiro H, Elinav E.

    READ MORE
  • Year: 2016

    The role of the gut microbiome in regulation of the host circadian rhythmicity.

    Rozin S, Elinav E.

    READ MORE
  • Year: 2016

    Integration of innate immune signaling

    Thaiss CA, Levy M, Itav S, Elinav E.

    READ MORE
  • Year: 2016

    The microbiota and its modulation in immune-mediated disorders. In: The future of immunosuppression: Immune re-balancing (eds. Diana Boraschi and Giselle Penton-Rol).

    Pevsner-Fischer M, Rot C, Tuganbaev T, Elinav E

  • Year: 2015

    Nuclear retention of mRNA in mammalian tissues

    Halpern KB, Caspi I, Lemze D, Levy M, Landen S, Elinav E, Ulitsky I, Itzkovitz
 S.

    READ MORE
  • Year: 2015

    Epithelial IL-18 equilibrium controls barrier function in colitis

    Nowarski R, Jackson R, Gagliani N, de Zoete MR, Palm NW, Bailis W, Low JS, Harman CCD, Graham M, Elinav E, Flavell
 RA.

  • Year: 2015

    Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling

    Levy M, Thaiss CA, Zeevi D, Dohnalova L, Zilberman-Schapira G, Ali Mahdi G, David E, Savidor A, Korem T, Herzig Y, Pevsner-Fischer M, Shapiro H, Christ A, Harmelin A, Halpern Z, Latz E, Flavell RA, Amit I, Segal E, Elinav E.

    READ MORE
  • Year: 2015

    Personalized nutrition by prediction of glycemic responses

    Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador, D, Avnit-Sagi T, Lotan-Pompan M, Suez J, Ali Mahdi J, Matot E, Malka G, Kosower N, Rein M, Zilberman-Schapira G, Dohnalova L, Pevsner-Fischer M, Bikovsky R, Halpern Z, Elinav E(co-corresponding last author), Segal E.

    READ MORE
  • Year: 2015

    Chronobiomics: The biological clock as a new principle in host–microbial interactions

    Thaiss CA, Levy M, Elinav E.

    READ MORE
  • Year: 2015

    A day in the life of the meta-organism: diurnal rhythms of the intestinal microbiome and its host

    Thaiss CA, Zeevi D, Levy M, Segal E, Elinav E.

    READ MORE
  • Year: 2015

    NF-kB regulation by NLRs: T cells join the club

    Thaiss CA, Elinav E.

    READ MORE
  • Year: 2015

    Taming the inflammasome

    Levy M, Thaiss CA, Elinav E.

    READ MORE
  • Year: 2015

    Inflammasomes and the microbiota—partners in the preservation of mucosal homeostasis

    Levy M, Thaiss CA, Katz MN, Suez J, Elinav E.

    READ MORE
  • Year: 2015

    Non-caloric artificial sweeteners and the microbiome: findings and challenges

    Suez J, Korem T, Zilberman-Schapira G, Segal E, Elinav E.

    READ MORE
  • Year: 2014

    Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis

    Thaiss CA, Zeevi D, Levy M, Zilberman-Schapira G, Suez J, Tengeler AC, Abramson L, Katz MN, Korem T, Zmora N, Kuperman Y, Biton I, Gilad S, Harmelin A, Shapiro H, Halpern Z, Segal E, Elinav E.

    READ MORE
  • Year: 2014

    Artificial sweeteners induce glucose intolerance by altering the gut microbiota

    Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E.

    READ MORE
  • Year: 2014

    A simple cage-autonomous method for the maintenance of the barrier status of germ-free mice during experimentation

    Hecht G, Bar-Nathan C, Milite G, Alon I, Moshe Y, Greenfeld L, Dotsenko L, Suez J, Levy M, Thaiss CA, Dafni H, Elinav E, Harmelin A.

    READ MORE
  • Year: 2014

    The cross talk between microbiota and the immune system: metabolites take center stage

    Shapiro H, Thaiss CA, Levy M, Elinav E.

    READ MORE
  • Year: 2014

    Exploring new horizons in microbiome research

    Thaiss CA, Elinav E.

    READ MORE
  • Year: 2014

    The fire within: Microbes inflame tumors

    Gagliani N, Hu B, Huber S, Elinav E, Flavell RA.

    READ MORE
  • Year: 2014

    NLRP6 inflammasome orchestrates the colonic host-microbial interface by Regulating Goblet Cell Mucus Secretion

    Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Philbrick WM, Elinav E (co-corresponding last author), Finlay BB (co-corresponding last author), Flavell RA.

    READ MORE
  • Year: 2014

    Inflammatory mechanism of infection-associated cancer. In: Infection and cancer (eds. Michael Shurin, Yasmin Thanavala and Nahed Ismail).

    Suez J, Levy M, Thaiss CA, Elinav E

  • Year: 2014

    Novel superactive leptin antagonists and their potential therapeutic applications

    Gertler A, Elinav E.

    READ MORE
  • Year: 2014

    Analysis of Microbiota Alterations in Inflammasome-Deficient Mice. In: Inflammasomes, Methods in Molecular Biology. (Ed. Christine De Nardo & Eicke Latz)

    Elinav E. Thaiss CA, Flavell RA.

  • Year: 2013

    The interplay between the innate immune system and the microbiota

    Thaiss CA, Levy M, Suez J, Elinav E.

    READ MORE
  • Year: 2013

    The microbiota: A new player in the etiology of colorectal cancer.

    Levy M, Thaiss CA, Elinav E.

    READ MORE
  • Year: 2013

    Inflammasomes and metabolic disease

    Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA.

    READ MORE
  • Year: 2013

    Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms.

    Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA.

    READ MORE
  • Year: 2013

    Role of the intestinal microbiome in liver disease

    Henao-Mejia J, Elinav E, Thaiss CA, Licona-Limon P, Flavell RA.

    READ MORE
  • Year: 2013

    Analysis of microbiota alterations in inflammasome-deficient mice.

    Elinav E, Thaiss CA, Flavell RA.

    READ MORE
  • Year: 2013

    Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer.

    Hu B, Elinav E (first co-author), Huber S, Strowig T, Hao LM, Hafemann A, Jin CC, Eisenbarth SC, Flavell RA.

    READ MORE
  • Year: 2013

    The intestinal microbiota in chronic liver disease

    Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA.

  • Year: 2013

    IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic

    Gertler A, Elinav E.

    READ MORE
  • Year: 2013

    Harnessing nanomedicine for mucosal theranostics-A silver bullet at last?

    Elinav E, Peer D.

    READ MORE
  • Year: 2013

    Inflammsomes and mucosal immune response. In: Innate immunity and intestinal microbiota (eds . HG wagner, Schloss Elmau)

    Elinav E., Henao-Mejia J, Flavell RA.

  • Year: 2013

    Integrative inflammasome activity in the regulation of intestinal mucosal immune responses

    Elinav E, Henao-Mejia J, Flavell RA.

    READ MORE
  • Year: 2013

    The Intestinal Microbiota in Chronic Liver Disease. In: Advances in Immunology. (Ed. S.Jayachandran).

    Henao-Mejia J, Elinav E. (first coauthor), Thaiss C, Flavell RA.

  • Year: 2012

    Preparation and characterization of mouse IL-22 and its four single-amino-acid muteins that act as IL-22 receptor-1 antagonists

    Niv-Spector L, Shpilman M, Levi-Bober M, Katz M, Varol C, Elinav E, Gertler A.

    READ MORE
  • Year: 2012

    NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells

    Eisenbarth SC, Williams A, Colegio OR, Meng H, Strowig T, Rongvaux A, Henao-Mejia J, Thaiss CA, Joly S, Gonzalez DG, Xu L, Zenewicz LA, Haberman AM, Elinav E, Kleinstein SH, Sutterwala FS, Flavell RA.

    READ MORE
  • Year: 2012

    Inflammasomes: far beyond inflammation

    Henao-Mejia J, Elinav E (first co-author), Strowig T, Flavell RA.

    READ MORE
  • Year: 2012

    Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

    Henao-Mejia J, Elinav E (first co-author), Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez J, Shulman GI, Gordon JI, Hoffman HM, Flavell RA.

    READ MORE
  • Year: 2012

    Inflammasomes in health and disease

    Strowig T, Henao-Mejia J, Elinav E (first co-author), Flavell RA.

    READ MORE
  • Year: 2011

    Utilization of Murine Colonoscopy for Orthotopic Implantation of Colorectal Cancer

    Zigmond E, Halpern Z, Elinav E, Brazowski E, Jung S, Varol C.

    READ MORE
  • Year: 2011

    Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation

    Hu B, Elinav E (first co-author), Flavell RA.

    READ MORE
  • Year: 2011

    Genetic engineering of regulatory T cells. In: Regulatory T cells. (Ed. Frank Columbus).

    Elinav E. Eshhar Z. 

  • Year: 2011

    NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis

    Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, Flavell RA.

    READ MORE
  • Year: 2011

    Regulation of the antimicrobial response by NLR proteins

    Elinav E, Strowig T, Henao-Mejia J, Flavell RA.

    READ MORE
  • Year: 2011

    Development and characterization of high affinity leptins and leptin antagonists

    Shpilman M, Niv-Spector L, Katz M, Varol C, Solomon G, Ayalon-Soffer M, Boder E, Halpern Z, Elinav E, Gertler A.

    READ MORE
  • Year: 2010

    Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4

    Hu B, Elinav E, Huber S, Booth CJ, Strowig T, Jin C, Eisenbarth SC, Flavell RA.

    READ MORE
  • Year: 2010

    CCL2 (pM Levels) as a therapeutic agent in inflammatory bowel disease models in mice

    Maharshak N, Hart G, Ron E, Zelman E, Sagiv A, Arber N, Brazowski E, Margolit R, Elinav E, Shachar I.

    READ MORE
  • Year: 2009

    Intestinal lamina propria dendritic cell subsets have different origin and functions

    Varol C, Vallon-Eberhard A, Elinav E, Aychek T, Shapira Y, Luche H, Fehling HJ, Hardt WD, Shakhar G, Jung S.

    READ MORE
  • Year: 2009

    Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity

    Elinav E, Niv-Spector L, Katz M, Price TO, Ali M, Yacobovitz M, Solomon G, Reicher S, Lynch JL, Halpern Z, Banks WA, Gertler A.

    READ MORE
  • Year: 2009

    Genetically engineered regulatory T cells ameliorate colitis through antigen-specific activation of TNP-specific chimeric receptor

    Elinav E, Adam N, Waks T, Eshhar Z.

  • Year: 2009

    Utilization of murine laparoscopy for continuous in-vivo assessment of the liver in multiple disease models

    Shapira Y, Katz M, Ali M, Kaplan M, Brazowski E, Halpern Z, Elinav E.

    READ MORE
  • Year: 2009

    Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor

    Elinav E, Adam N, Waks T, Eshhar Z.

    READ MORE
  • Year: 2009

    Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding

    Cohen MJ, Sahar T, Benenson S, Elinav E, Brezis M, Soares-Weiser K.

    READ MORE
  • Year: 2009

    Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function

    Elinav E, Ali M, Bruck R, Brazowski E, Phillips A, Shapira Y, Katz M, Solomon G, Halpern Z, Gertler A.

    READ MORE
  • Year: 2008

    Inhibition of leptin activity for treatment of autoimmunity. In: Leptin and leptin antagonists. (Ed. Arieh Gertler)

    Elinav E., Gertler A.

  • Year: 2008

    Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice

    Elinav E, Waks T, Eshhar Z.

    READ MORE
  • Year: 2007

    Antigen-specific regulatory T cells redirected with chimeric receptor cure acute colitis

    Eshhar Z, Waks T, Elinav E.

  • Year: 2007

    Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity

    Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, Keinan-Boker L, Broide E, Ackerman Z, Kaluski DN, Lev B, Shouval D.

    READ MORE
  • Year: 2007

    Late-onset sarcoidosis after liver transplantation for primary biliary cirrhosis

    Gur C, Lalazar G, Doviner V, Fridlender ZG, Molcho V, Abu-Much S, Shalit M, Elinav E.

    READ MORE
  • Year: 2006

    Low alanine aminotransferase activity in older people is associated with greater long-term mortality

    Elinav E, Ackerman Z, Maaravi Y, Ben-Dov IZ, Ein-Mor E, Stessman J.

    READ MORE
  • Year: 2006

    Off-pump coronary artery bypass grafting in a patient with Child class C liver cirrhosis awaiting liver transplantation

    Ben Ari A, Elinav E, Elami A, Matot I.

    READ MORE
  • Year: 2006

    Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor

    Elinav E, Ben-Dov IZ, Shapira Y, Daudi N, Adler R, Shouval D, Ackerman Z.

    READ MORE
  • Year: 2006

    Renal vein thrombosis and membranous glomerulopathy in a patient homozygote for factor V Leiden mutation: a mere coincidence?

    Elinav E, Rubinger D, Hiller N, Pizov G, Nadir E, Shapira Y, Heyman SN.

    READ MORE
  • Year: 2006

    Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping

    Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O, Gomori M, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

    READ MORE
  • Year: 2006

    Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation

    Elinav E, Abd-Elnabi A, Pappo O, Bernstein I, Klein A, Engelhardt D, Rabbani E, Ilan Y.

    READ MORE
  • Year: 2006

    Prevention of hepatic cirrhosis by hydroxyl radical scavengers. In: Progress in Liver Cirrhosis Research. (Ed. Frank Columbus)

    Elinav E., Brook R. 

  • Year: 2006

    Acute liver failure. In: Liver Diseases: Biochemical Mechanisms and New Therapeutic Insights. (Eds. Scott Friedman, Shakir Ali, Derek Mann)

    Elinav E., Brook R.

  • Year: 2006

    Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels

    Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O, Gomori M, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

    READ MORE
  • Year: 2005

    Correlation Between Serum Alanine Aminotransferase Activity and Age: An Inverted U Curve Pattern

    Elinav E, Ben-Dov IZ, Ackerman E, Kiderman A, Glikberg F, Shapira Y, Ackerman Z.

    READ MORE
  • Year: 2005

    Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes

    Margalit M, Abu Gazala S, Alper R, Elinav E, Klein A, Doviner V, Sherman Y, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

    READ MORE
  • Year: 2005

    Near-fatal amitraz intoxication: the overlooked pesticide.

    Elinav E, Shapira Y, Ofran Y, Hassin T, Ben-Dov IZ.

    READ MORE
  • Year: 2005

    POEMS Syndrome: Failure of Newly Suggested Diagnostic Criteria to Anticipate the Development of the Syndrome

    Ofran Y, Elinav E.

    READ MORE
  • Year: 2005

    Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes

    Margalit M, Shibolet O, Klein A, Elinav E, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

    READ MORE
  • Year: 2005

    The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy.

    Elinav E, Ben-Dov I, Hai-Am E, Ackerman Z, Ofran Y.

    READ MORE
  • Year: 2004

    Fatal voluntary salt intake resulting in the highest ever documented sodium plasma level in adults (255 mmol L-1 ): a disorder linked to female gender and psychiatric disorders

    Ofran Y, Lavi D, Opher D, Weiss TA, Elinav E.

    READ MORE
  • Year: 2004

    Low dose warfarin treatment for calcinosis in patients with systemic sclerosis

    Cukierman T, Elinav E, Korem M, Chajek-Shaul T.

    READ MORE
  • Year: 2004

    Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up study.

    Shibolet O, Elinav E, Ilan Y, Safadi R, Ashur Y, Eid A, Zamir G, Fridlander M, Bdolah-Abram T, Shouval D, Admon D.

    READ MORE
  • Year: 2004

    Does any lower gastrointestinal bleeding in patients suffering from hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu) necessitate a full colonic visualization?

    Elinav E, Salameh-Giryes S, Ackerman Z, Goldschmidt N, Nissan A, Chajek-Shaul T.

    READ MORE
  • Year: 2004

    Episodic macroglossia as the sole manifestation of angiotensin-converting enzyme inhibitor-induced angioedema.

    Elinav E, Rabinowitz Y, Lorberbaum M, Nisanewitz V.

    READ MORE
  • Year: 2004

    Hyperplastic gastropathy as a presenting manifestation of systemic lupus erythematosus

    Elinav E, Korem M, Ofran Y, Migdal A, Doviner V, Hiler N, Aamar S, Bursztyn M.

    READ MORE
  • Year: 2003

    Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis

    Elinav E, Planer D, Gatt ME.

    READ MORE
  • Year: 2003

    Licorice consumption causing severe hypokalemic paralysis

    Elinav E, Chajek-Shaul T.

    READ MORE
  • Year: 2002

    Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic type iv renal tubular acidosis

    Elinav E, Ackerman Z, Gottehrer NP, Heyman SN.

    READ MORE
  • Year: 2002

    Constrictive Pericarditis Complicating Endovascular Pacemaker Implantation

    Elinav E, Leibowitz D.

    READ MORE
  • Year: 2002

    Improvement in cholesterol emboli syndrome after iloprost therapy

    Elinav E, Chajek-Shaul T, Stern M.

    READ MORE